| memantine / Generic mfg. |
NCT03954613: Evaluation of the Contribution of Regular Cognitive Exercises to Treatment in Patients With Alzheimer's Disease |
|
|
| Recruiting | 4 | 198 | RoW | Ebicomb, Donepezil-Memantine | Neutec Ar-Ge San ve Tic A.Åž | Alzheimer Disease, Cognitive Change | 03/23 | 03/24 | | |
2006-000860-10: An Open-Label Study Investigating the Specific Effects of Memantine in Institutionalised Patients with Alzheimer’s Disease |
|
|
| | 3 | 40 | Europe | Ebixa, Lu 00-800, Ebixa 10 mg film-coated tablets, Ebixa 10 mg film-coated tablets | H. Lundbeck A/S | Effects of memantine treatment in institutionalised patients with Alzheimer\'s Disease. | | 09/06 | | |
2021-002179-21: A phase 3 study to evaluate the safety and efficacy of masitinib as add-on therapy in patients with mild to moderate Alzheimer's disease treated with standard of care: cholinesterase inhibitors, memantine |
|
|
| Not yet recruiting | 3 | 600 | Europe | Masitinib, AB1010, Film-coated tablet | AB Science, ABScience, AB Science, ABScience | Alzheimer's disease, Diseases [C] - Nervous System Diseases [C10] | | | | |
2017-004125-32: A randomised, double blind, placebo controlled trial to evaluate the safety, efficacy and pharmakokinetics of Pleconaril as an add on to AchEI/memantine for treatment of patients with Alzheimer’s disease |
|
|
| Ongoing | 2 | 120 | Europe | pleconaril, Capsule, hard | Apodemus Aktiebolag, Apodemus AB | Alzheimer's disease, Alzheimer's disease, Diseases [C] - Nervous System Diseases [C10] | | | | |
NCT04538066: Bryostatin Treatment of Moderately Severe Alzheimer's Disease |
|
|
| Completed | 2 | 117 | US | Bryostatin 1, Placebo | Neurotrope Bioscience, Inc., National Institutes of Health (NIH), National Institute on Aging (NIA) | Alzheimer Disease | 11/22 | 11/22 | | |
